emerg
infecti
diseas
eid
pose
major
threat
public
health
secur
given
dynam
natur
signific
impact
eid
effect
way
prevent
protect
develop
vaccin
advanc
system
biolog
approach
provid
integr
way
understand
complex
immun
respons
pathogen
lead
greater
understand
eid
pathogenesi
facilit
evalu
newli
develop
vaccineinduc
immun
time
manner
recent
year
advanc
high
throughput
technolog
enabl
research
success
appli
system
biolog
method
analyz
immun
respons
varieti
pathogen
vaccin
despit
recent
advanc
comput
biolog
challeng
imped
wider
applic
system
biolog
approach
review
highlight
recent
advanc
field
system
immunolog
vaccinolog
present
way
system
biologybas
platform
appli
acceler
deeper
understand
molecular
mechan
immun
eid
emerg
infecti
diseas
eid
defin
newli
appear
infect
popul
diseas
previous
exist
rapidli
emerg
incid
geograph
rang
eid
often
initi
pathogen
chang
pathogen
emerg
pathogen
highli
like
zoonot
broad
rang
host
vectorborn
new
human
pathogen
especi
like
continu
emerg
mainli
mammal
bird
forese
futur
reason
effect
global
surveil
system
novel
pathogen
need
due
divers
natur
antigen
variat
emerg
pathogen
variou
strategi
evad
immun
system
eid
continu
pose
difficult
challeng
clinician
public
health
profession
research
global
understand
eid
pathogenesi
begin
investig
immun
respons
emerg
pathogen
immun
respons
consequ
intric
elabor
network
larg
number
special
cell
organ
oper
space
time
respons
pathogen
immun
system
must
orchestr
complex
interact
activ
larg
number
divers
cell
type
therebi
recogn
elimin
pathogen
abil
respond
quickli
effect
control
invad
pathogen
achiev
innat
adapt
immun
system
innat
immun
provid
fast
immedi
sens
pathogen
wherea
adapt
immun
respons
late
longlast
protect
immun
memori
abl
respond
quickli
futur
infect
major
goal
vaccin
mimic
natur
induc
memori
respons
train
immun
system
alter
form
pathogen
compon
pathogen
caus
ill
therefor
success
vaccin
larg
depend
qualiti
vaccineinduc
immunogen
thu
far
vaccin
prepar
tradit
method
involv
isol
infecti
agent
attenu
inactiv
expos
immun
system
although
tradit
approach
proven
effici
pathogen
rel
low
antigen
variabl
smallpox
polio
measl
mump
rubella
approach
optim
provid
adequ
protect
recent
appear
eid
avian
influenza
viru
infect
ebola
hemorrhag
fever
dengu
fever
thu
novel
system
approach
requir
predict
protect
immun
respons
high
throughput
sequenc
bioinformat
analysi
identifi
potenti
antigen
target
guid
acceler
vaccin
develop
recent
year
system
biolog
rapidli
emerg
new
disciplin
research
move
tradit
reductionist
approach
system
approach
rapidli
increas
amount
novel
omic
data
relev
data
avail
recent
advanc
nextgener
sequenc
ng
highthroughput
technolog
enabl
research
comprehens
assess
whole
genom
transcriptom
proteom
metabolom
cell
tissu
system
approach
appli
field
immunolog
vaccin
develop
sinc
integr
genom
transcriptom
metabolom
give
global
pictur
nearli
gene
protein
cell
particip
immun
respons
pathogen
vaccin
review
highlight
major
eid
signific
global
impact
vaccin
current
exist
summar
recent
eid
south
korea
moreov
discuss
variou
system
biolog
approach
examin
strategi
offer
signific
potenti
discov
new
biomark
pathogen
predictor
protect
immun
overal
suggest
system
biolog
approach
would
like
enhanc
understand
pathogenesi
newli
emerg
pathogen
acceler
develop
next
gener
vaccin
eid
recent
global
outbreak
eid
ebola
zika
viru
zikv
diseas
remind
world
immin
threat
unexpect
pathogen
eid
result
infecti
agent
recent
appear
exist
rapidli
increas
incid
major
pathogen
includ
highli
pathogen
avian
influenza
hpai
viru
sever
fever
thrombocytopenia
syndrom
sft
viru
sftsv
zikv
dengu
viru
denv
middl
east
respiratori
syndrom
coronaviru
merscov
southeast
asia
epicent
mani
emerg
diseas
past
decad
tabl
show
characterist
recent
occur
current
eid
occur
southeast
asia
centuri
diseas
pose
major
threat
public
health
potenti
caus
high
incid
fatal
among
global
commun
therefor
investig
emerg
pathogenesi
eid
requir
public
health
safeti
sever
factor
contribut
emerg
new
pathogen
microbi
adapt
genom
chang
increas
frequenc
intern
travel
commerc
climat
chang
given
microbi
adapt
driven
evolut
microb
surviv
divers
environ
microb
evolv
chang
genom
rna
virus
carri
rna
genet
materi
quickli
adapt
exploit
differ
host
high
error
rate
viral
enzym
rnadepend
rna
polymeras
replic
segment
natur
faulti
replic
mechan
orthomyxovirus
promot
genet
variabl
frequent
reassort
event
result
genet
divers
novel
genom
constel
infect
host
exampl
hemagglutinin
surfac
protein
influenza
viru
undergo
antigen
drift
shift
acquir
new
infect
evad
recognit
immun
system
anoth
import
consequ
unstabl
genom
makeup
rna
virus
potenti
interspeci
transmiss
anim
host
human
accordingli
recent
emerg
avian
influenza
virus
could
devast
immunolog
popul
pose
seriou
threat
public
health
anoth
major
factor
respons
eid
increas
incid
intern
travel
commerc
frequent
use
air
travel
enabl
increas
global
intern
tourism
expand
time
last
decad
mani
travel
infect
becom
carrier
eid
pathogen
without
knowledg
viral
incub
period
frequent
last
week
thu
imposs
success
monitor
travel
eid
earli
stage
infect
surveil
travel
respiratori
ill
especi
difficult
respiratori
virus
propag
easili
caus
outbreak
nonendem
diseas
area
exampl
south
korea
experienc
mer
outbreak
initi
man
travel
bahrain
locat
middl
east
despit
south
korea
nonendem
area
mer
case
reportedli
infect
merscov
outbreak
number
highest
among
mer
nonendem
area
lastli
climat
chang
contribut
ecolog
chang
thu
contribut
emerg
eid
last
year
temperatur
earth
increas
approxim
global
warm
contribut
climat
chang
throughout
world
warmer
climat
provid
favor
environ
surviv
complet
vector
life
cycl
particular
mosquito
popul
wide
establish
across
europ
well
tropic
region
africa
south
asia
exampl
prior
nine
countri
experienc
dengu
fever
transmit
mosquito
occur
mostli
tropic
region
howev
today
case
denvassoci
diseas
found
countri
moreov
climat
chang
frequent
invok
primari
caus
expans
incid
tickborn
diseas
particularli
lyme
diseas
wide
distribut
tick
vector
increas
preval
tickborn
pathogen
given
rise
temperatur
acceler
cycl
develop
product
egg
densiti
distribut
tick
popul
therefor
necessari
explor
climat
chang
alter
distribut
dynam
risk
vectorborn
diseas
south
korea
current
sever
major
eid
hpai
infect
sftsv
infect
merscov
infect
denvzikvassoci
diseas
could
pose
great
risk
public
health
near
futur
sinc
outbreak
hpai
viru
alarm
caus
signific
econom
loss
public
health
concern
hpai
viru
undergo
rapid
evolut
gene
mutat
reassort
homolog
recombin
avian
speci
vertebr
reservoir
host
although
evid
thu
far
suggest
direct
transmiss
hpai
viru
human
korea
concern
remain
due
potenti
avian
influenza
virus
circul
poultri
becom
transmiss
speci
directli
infect
human
addit
due
recent
increas
zoonot
infect
poultri
persist
human
infect
china
influenza
viru
remain
public
health
threat
moreov
februari
case
human
infect
novel
lowli
pathogen
viru
report
anhui
shanghai
region
eastern
china
april
total
number
case
exceed
death
sever
fever
thrombocytopenia
syndrom
viru
infect
sft
infect
emerg
tickborn
hemorrhag
fever
first
describ
rural
area
china
caus
agent
sftsv
novel
phleboviru
bunyavirida
famili
sft
case
first
report
china
japan
korea
major
clinic
sign
symptom
sft
includ
high
fever
gastrointestin
symptom
thrombocytopenia
leukocytopenia
multiorgan
dysfunct
averag
casefat
rate
moreov
bone
marrow
suppress
hemophagocyt
histiocyt
commonli
found
korean
patient
sft
infect
despit
avail
treatment
sft
infect
yet
earli
plasma
exchang
implement
prove
benefici
moreov
sftsv
believ
transmit
tick
bite
howev
suspect
case
humantohuman
transmiss
china
korea
although
humantohuman
transmiss
consid
rare
urgent
necessari
develop
effect
diagnost
prevent
tool
protect
sftsv
maintain
continu
surveil
viru
thought
spread
via
blood
mucos
secret
merscov
infect
respiratori
diseas
caus
merscov
posit
singl
strand
rna
viru
although
detail
mode
transmiss
period
viru
shed
infect
patient
fulli
understood
nosocomi
infect
process
anticip
main
transmiss
process
merscov
first
identifi
middl
east
dromedari
camel
found
carri
merscov
without
respiratori
symptom
fatal
rate
merscov
infect
human
approxim
symptom
includ
fever
cough
breath
difficulti
sinc
countri
includ
saudi
arabia
china
malaysia
jordan
report
mer
outbreak
saudi
arabia
report
approxim
outbreak
surprisingli
south
korea
nonendem
area
mer
experienc
mer
outbreak
thought
travel
return
bahrain
carri
mer
viru
caus
outbreak
case
death
substanti
impact
south
korean
economi
given
continuum
emerg
larg
magnitud
mer
outbreak
variou
region
studi
requir
bolster
capabl
time
detect
effect
control
prevent
merscov
consequ
global
warm
zikvdenvassoci
diseas
potenti
eid
could
aris
south
korea
denv
zikv
mainli
transmit
aed
albopictu
aed
aegypti
mosquito
respect
dengu
fever
major
public
health
concern
mani
part
tropic
subtrop
four
differ
serotyp
current
cocircul
dengueendem
area
pathogenesi
dengu
fever
uniqu
regard
antibodydepend
immun
enhanc
associ
denv
wherea
primari
infect
usual
confer
durabl
lifelong
protect
reinfect
homolog
denv
serotyp
secondari
infect
virus
heterolog
denv
serotyp
frequent
occur
result
sever
patholog
host
thu
uniqu
complex
denv
pathogenesi
effect
immun
enhanc
pose
great
challeng
develop
safe
effect
denv
vaccin
even
though
south
korea
region
dengu
epidem
mani
import
denv
infect
case
south
korea
number
increas
due
increas
travel
southeast
asia
likewis
zikv
anoth
emerg
mosquitoborn
pathogen
belong
famili
flavivirida
close
relat
pathogen
public
health
import
includ
yellow
fever
viru
denv
japanes
enceph
viru
west
nile
viru
first
case
human
infect
zikv
report
uganda
usual
zikv
infect
result
asymptomat
clinic
featur
case
zikv
infect
lead
fatal
microcephali
infant
guillainbarr
syndrom
adult
increas
case
zikv
infect
america
mani
asian
countri
includ
india
philippin
taiwan
vietnam
report
zikv
outbreak
although
south
korea
consid
nonendem
region
aed
aegyptitransmit
diseas
first
patient
infect
zikv
report
south
korea
patient
stay
brazil
week
upon
arriv
south
korea
complain
variou
symptom
includ
fever
eyebal
pain
maculopapular
rash
given
asia
endem
zikv
infect
climat
south
korea
chang
year
matter
time
mosquitoborn
eid
becom
endem
south
korea
thu
need
prepar
protect
mosquitoborn
eid
summar
addit
viru
genet
variat
complex
environment
factor
includ
ecolog
behavior
influenc
import
contribut
compon
recent
emerg
viral
diseas
recent
ebola
zika
outbreak
shown
world
unprepar
detect
local
outbreak
respond
quickli
enough
prevent
becom
global
pandem
given
great
concern
public
health
owe
speed
increas
volum
global
transport
abil
rapidli
develop
deliv
vaccin
new
unknown
diseas
emerg
offer
best
hope
outpac
eid
outbreak
save
live
avert
disastr
econom
consequ
mention
due
ecolog
environment
demograph
factor
increas
exposur
emerg
pathogen
eid
case
increas
preval
global
togeth
ongo
evolut
viral
microbi
variant
select
drug
resist
factor
contribut
continu
emerg
eid
therefor
urgent
need
effect
surveil
control
strategi
well
rapid
vaccin
develop
earli
warn
eid
depend
abil
identifi
unusu
earli
possibl
inform
therefor
essenti
achiev
use
system
biolog
tool
system
biolog
approach
understand
live
system
focus
model
divers
type
highdimension
interact
develop
comprehens
understand
complex
phenotyp
manifest
system
system
biolog
tool
enabl
us
develop
valid
predict
model
infecti
diseas
initi
progress
outcom
model
deriv
studi
architectur
dynam
systemswid
hostpathogen
molecular
interact
network
infect
ideal
integr
dataset
gener
combin
highthroughput
multiom
data
transcriptom
proteom
metabolom
lipidom
etc
use
construct
predict
model
network
dynam
interact
biolog
compon
complex
pathogenhost
system
particular
year
dedic
effort
highthroughput
rna
sequenc
rnaseq
technolog
power
way
profil
transcriptom
great
effici
high
accuraci
employ
variou
viral
infect
diseas
studi
prove
rnaseq
technolog
potenti
reveal
dynam
pathogen
genom
alter
system
chang
host
pathogen
gene
express
process
infect
thu
approach
appli
eid
research
inform
help
acceler
uncov
pathogenesi
novel
infect
interact
mechan
emerg
pathogen
notabl
exampl
sever
group
taken
advantag
rnaseq
technolog
provid
novel
insight
zikv
infect
may
caus
microcephali
short
period
time
nowakowki
et
al
use
singlecel
rnaseq
immunohistochemistri
first
report
axl
viral
receptor
zikv
highli
express
human
radial
glial
cell
astrocyt
endotheli
cell
microglia
develop
human
cortex
progenitor
cell
develop
retina
addit
onorati
et
al
analyz
zikvinfect
neuron
progenitor
cell
identifi
transcript
chang
caus
viru
use
techniqu
includ
singlecel
rnaseq
describ
deriv
character
neocort
spinal
cord
neuroepitheli
stem
cell
model
earli
human
neurodevelop
zikvrel
neuropathogenesi
data
may
lead
signific
advanc
effort
develop
vaccin
zikv
discuss
extens
knowledg
factor
underli
eid
pathogenesi
help
develop
effect
prevent
strategi
protect
eid
essenti
first
step
establish
effect
global
diseas
surveil
give
earli
warn
emerg
infect
achiev
rapid
portabl
inexpens
highthroughput
screen
eid
pathogen
furthermor
systemslevel
informat
reduc
time
requir
experiment
immunolog
vaccinolog
also
promot
identif
ration
design
novel
vaccin
candid
determin
vaccineinduc
immun
prompt
escal
control
measur
necessari
facilit
outbreak
track
vaccin
one
greatest
success
histori
mankind
howev
despit
global
effort
develop
vaccin
major
infecti
diseas
correl
protect
still
poorli
defin
mani
exist
vaccin
moreov
pathogen
evad
suppress
immun
respons
human
genet
variabl
contribut
host
suscept
infecti
diseas
vaccin
respons
although
erad
smallpox
one
mani
success
global
immun
program
mani
vaccin
challeng
remain
especi
design
effect
vaccin
major
killer
aid
dengu
fever
malaria
furthermor
urgent
need
develop
vaccin
eid
includ
diseas
mention
neglect
diseas
caus
chikungunya
hendra
nipah
virus
recent
studi
use
system
biolog
approach
identifi
molecular
network
orchestr
immun
vaccin
human
potenti
defin
correl
protect
first
attempt
approach
made
one
success
vaccin
ever
develop
yellow
fever
vaccin
live
attenu
viru
vaccin
singl
shot
yellow
fever
vaccin
confer
protect
vaccine
result
longlast
immun
strong
neutral
antibodi
respons
robust
cell
respons
two
independ
group
simultan
publish
gene
express
profil
data
blood
sampl
vaccine
within
day
vaccin
molecular
signatur
help
research
predict
magnitud
vaccineinduc
immun
provid
novel
insight
dynam
natur
innat
adapt
immun
respons
vaccin
particular
querec
et
al
report
also
known
known
sensor
low
amino
acid
level
insid
cell
frequent
found
blood
vaccine
strongli
correl
magnitud
later
cell
respons
vaccin
subsequ
system
biolog
approach
extend
influenza
vaccin
studi
identifi
molecular
mechan
influenza
vaccineinduc
immun
challeng
yellow
fever
vaccin
studi
given
variat
antigen
match
vaccin
circul
influenza
strain
contribut
vaccin
efficaci
nakaya
et
al
compar
transcriptom
data
given
either
trival
influenza
vaccin
tiv
live
attenu
influenza
vaccin
laiv
vaccin
induc
express
gene
involv
innat
immun
pathway
although
laiv
induc
higher
express
sever
interferonrel
gene
similar
anoth
live
attenu
vaccin
therefor
data
demonstr
live
dead
influenza
vaccin
clearli
result
differenti
vaccineinduc
immun
among
mani
factor
determin
efficaci
vaccin
age
vaccine
import
fact
older
adult
children
vulner
sever
often
lethal
influenza
viru
infect
due
decreas
vaccin
efficaci
thu
use
adjuv
help
improv
efficaci
influenza
viru
vaccin
children
older
adult
support
idea
nakaya
et
al
conduct
blood
transcriptom
analysi
children
less
year
old
compar
immunogen
tiv
without
adjuv
oilinwat
adjuv
known
increas
magnitud
antibodi
respons
inactiv
vaccin
interestingli
potent
antibodi
respons
gener
subject
receiv
vaccin
correl
strong
transcript
signatur
interferon
signal
network
blood
sampl
addit
transcriptom
analysi
systemslevel
approach
proteom
metabolom
lipidom
provid
greater
depth
evalu
correl
vaccineinduc
immun
latest
research
dr
pulendran
group
analyz
vaccineinduc
immun
multiscal
way
differ
age
group
healthi
adult
immun
shingl
vaccin
zostavax
author
present
integr
data
peripher
blood
mononuclear
cell
pbmc
transcriptom
flow
cytometri
blood
cell
popul
plasma
cytokin
analysi
metabolom
integr
data
reveal
transcriptom
associ
metabol
correl
vaccin
immun
interestingli
analysi
reveal
sterol
regulatori
bind
target
potenti
key
integr
antibodi
follicular
helper
cell
respons
therefor
data
suggest
blood
cell
potenti
regul
gene
transcript
respons
metabol
cue
suggest
valu
integr
divers
systemslevel
data
given
vaccin
usual
initi
broad
polyfunct
persist
immun
respons
integr
effector
cell
immun
system
import
scientist
understand
complex
dynam
divers
qualiti
immun
respons
therefor
innov
tool
use
singl
cell
technolog
omic
approach
enabl
research
quantit
examin
entir
class
molecul
singl
cell
level
facilit
understand
function
divers
immun
respons
shown
fig
use
system
biolog
tool
fig
process
system
vaccinolog
approach
system
biolog
approach
appli
clinic
trial
lead
gener
new
hypothes
test
ultim
lead
better
vaccin
develop
exampl
correl
vaccineinduc
immun
clinic
trial
profil
detail
highthroughput
technolog
rnasequenc
proteom
metabolom
highthroughput
data
thu
gener
integr
use
bioinformat
tool
use
creat
hypothes
biolog
mechan
underli
vaccin
efficaci
immunogen
hypothes
test
anim
model
vitro
human
system
insight
gain
experiment
guid
identif
biomark
design
develop
new
vaccin
thu
system
vaccinolog
approach
provid
translat
solut
novel
enhanc
vaccin
develop
creas
understand
vaccinemedi
immun
help
scientist
better
posit
identifi
correl
vaccin
immunogen
make
progress
toward
develop
new
enhanc
vaccin
therapeut
thu
far
review
recent
advanc
field
system
immunolog
vaccinolog
present
system
biologybas
platform
appli
acceler
deeper
understand
molecular
mechan
immun
eid
despit
recent
advanc
remain
comput
biolog
challeng
regard
system
biolog
approach
immun
respons
vaccin
affect
wide
rang
confound
factor
includ
cellular
popul
molecular
individu
technic
factor
scientist
face
mani
challeng
potenti
limit
analysi
systemslevel
informat
challeng
limit
describ
fig
conduct
largescal
system
biolog
approach
one
consid
follow
limit
although
previou
studi
involv
mathemat
model
dynam
immun
respons
provid
clue
optim
experiment
design
systemslevel
experi
care
design
control
variabl
term
time
point
furthermor
given
immun
respons
occur
consequ
coordin
event
among
mani
immun
cell
space
time
import
understand
immun
cell
respond
cell
popul
singl
cell
level
singlecel
sequenc
allow
research
examin
genom
transcriptom
individu
cell
thu
provid
highresolut
view
celltocel
variat
techniqu
use
assess
individu
contribut
singl
cell
complex
tissu
profil
transcriptom
unbias
manner
addit
technolog
problem
system
biolog
approach
resolv
solut
shown
tabl
addit
despit
high
cost
high
throughput
analysi
limit
number
human
sampl
minim
confound
factor
best
maxim
sampl
size
achiev
appropri
statist
power
besid
sampl
size
anoth
major
confound
variabl
system
vaccinolog
approach
observ
transcriptom
chang
may
result
new
induct
gene
express
may
simpli
reflect
chang
cellular
composit
pbmc
compart
given
imposs
obtain
cellular
tissu
sampl
lymph
node
spleen
healthi
human
subject
post
vaccin
vaccin
efficaci
test
must
perform
pbmc
drawn
preand
postvaccin
limit
optim
understand
vaccineinduc
protect
immun
respons
one
keep
mind
pbmc
includ
mix
dynam
cell
popul
thu
may
dynam
event
occur
within
lymphoid
compart
pbmc
therefor
inform
precis
determin
transcriptom
sort
cell
subset
b
cell
cell
natur
killer
cell
macrophag
dendrit
cell
emerg
technolog
structurebas
antigen
design
synthet
vaccinolog
herald
new
era
vaccin
discoveri
develop
exampl
revers
vaccinolog
process
recent
appli
base
notion
protect
antigen
could
identifi
determin
antibodi
repertoir
infect
vaccin
individu
fig
demonstr
identif
novel
effect
epitop
use
ng
highthroughput
robot
crystal
platform
enabl
precis
predict
epitop
target
effici
antibodi
gener
webbas
epitop
databas
vaccin
design
resourc
protein
structur
comparison
resourc
help
improv
understand
immun
respons
escap
evolut
pathogen
exampl
massiv
antibodi
engin
effort
improv
breadth
potenc
antibodi
given
import
neutral
antibodi
vaccin
protect
dissect
antibodi
variabl
region
use
revers
vaccinolog
tool
ration
approach
design
vaccin
ultim
lead
effect
vaccin
eid
recent
advanc
system
biologybas
technolog
enabl
scientist
investig
immun
respons
induc
pathogen
vaccin
greater
depth
ever
importantli
advanc
facilit
identif
robust
molecular
cellular
signatur
protect
immun
help
gener
diagnost
tool
reduc
length
cost
current
clinic
trial
potenti
bias
system
vaccinolog
data
analysi
applic
system
biolog
approach
field
immunolog
vaccinolog
face
mani
challeng
potenti
limit
potenti
challeng
factor
system
vaccinolog
analysi
divid
differ
categori
cellular
popul
molecular
individu
technic
aspect
fig
use
revers
vaccinolog
tool
vaccin
design
workflow
vaccin
design
use
revers
vaccinolog
shown
first
b
cell
plasma
cell
isol
infect
vaccin
individu
pcr
amplif
antibodi
gene
heavi
light
chain
lead
human
b
cell
repertoir
analysi
enabl
identif
protect
antibodi
use
sequenc
inform
antibodi
variabl
region
interact
antibodi
target
antigen
structur
character
use
predict
protect
epitop
use
crystallographi
protect
epitop
engin
produc
optim
immunogen
enhanc
deliveri
format
nanoparticl
technolog
adjuv
final
new
revers
vaccinologybas
antigen
test
human
system
approach
appli
eid
enabl
rapid
ration
design
vaccin
develop
thu
develop
field
vaccinologist
immunologist
bioinformatician
system
biologist
must
work
handinhand
advanc
understand
molecular
mechan
vaccin
induc
protect
immun
help
drive
develop
next
gener
vaccin
prevent
eid
